Updated

Updated · PR Newswire · Jul 10

Montréal Exchange Starts Curaleaf Options on July 13 as CURA Gains Derivatives Trading

Updated

Updated · PR Newswire · Jul 10

Montréal Exchange Starts Curaleaf Options on July 13 as CURA Gains Derivatives Trading

Q: Curaleaf options are now on the Montréal Exchange. What is the final hurdle to its coveted U.S. stock market listing?

The key remaining hurdle is federal regulatory clarity: Curaleaf’s path to a major U.S. exchange largely depends on the completion of the process to move all cannabis, not just state-licensed medical marijuana, from Schedule I to Schedule III. Curaleaf has already done much of the corporate preparation. It domesticated to Delaware, completed a 1-for-3 reverse stock split to better fit U.S. exchange price requirements, and has said it is ready to uplist when the window opens. The Montréal Exchange options listing is another sign of market maturity, but it does not solve the core U.S. issue. That issue is that Curaleaf is a multistate operator with both medical and adult-use cannabis businesses. While the Justice Department’s 2026 move put state-licensed medical cannabis into Schedule III, adult-use marijuana remains in a legally unresolved position for exchange purposes unless the broader DEA rescheduling process is completed. Until that happens, major U.S. exchanges, banks, clearing firms and other market gatekeepers still face legal and compliance questions. In practical terms, Curaleaf either needs the broader federal rescheduling to be finalized, or a framework that clearly allows companies to separate federally permissible medical operations from still-restricted adult-use operations in a way acceptable to exchanges and regulators. That is why the DEA’s ongoing hearing on broader rescheduling is widely viewed as the final hurdle to Curaleaf’s coveted U.S. listing.

2 articles · Updated · PR Newswire · Jul 10

July 13 is the expected start date for exchange-traded options on Curaleaf's subordinate voting shares on the Montréal Exchange under the symbol CURA.
The MX initiated the listing based on Curaleaf's market capitalization, share trading depth and growing institutional relevance; the company said it neither applied for nor controls the listing.
Listed options would let investors hedge risk, generate income and take directional positions, while potentially improving liquidity and price discovery by drawing in market makers and institutional traders.
No new shares will be issued, the listing will not dilute shareholders or raise proceeds for Curaleaf, and investors need take no action ahead of trading.